3002.41.00.00 - Vaccines for human medicine 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | Free |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3002.41.00.00, specifically covers vaccines intended for use in human medicine. These products are biological preparations designed to stimulate the immune system to provide immunity to a particular infectious disease. This includes vaccines for preventing diseases such as influenza, polio, measles, and COVID-19, among others. The key criterion for classification here is the intended recipient: humans.
It is crucial to distinguish this category from its sibling, 3002.42.00.00, which encompasses vaccines solely for veterinary medicine. While the manufacturing processes might be similar, the intended application – animal health versus human health – is the definitive factor for correct classification. Products not fitting into either human or veterinary vaccines, such as other immunological products, toxins, or microbial cultures, would fall under the residual category 3002.49.00.
As a leaf node, this HTS category does not have further subdivisions. Therefore, classification within 3002.41.00.00 relies on confirming that the product is indeed a vaccine and that its sole intended use is for the prevention or treatment of disease in humans. This includes a wide array of vaccine types, whether live, attenuated, inactivated, or subunit vaccines, as long as they are presented in a form suitable for human administration.